MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

Cyclacel Pharmaceuticals Inc

Fermé

13.66 311.45

Résumé

Variation du prix de l'action

24h

Actuel

Min

3.32

Max

19.2

Dividendes

By Dow Jones

Prochains Résultats

13 août 2025

Cyclacel Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 juil. 2025, 22:07 UTC

Principaux Mouvements du Marché

Trade Desk Rises on S&P 500 Inclusion

14 juil. 2025, 17:06 UTC

Principaux Mouvements du Marché

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 juil. 2025, 16:47 UTC

Acquisitions, Fusions, Rachats

NatWest to Sell Stake in Permanent TSB

14 juil. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

14 juil. 2025, 23:38 UTC

Market Talk

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 juil. 2025, 23:37 UTC

Market Talk

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 juil. 2025, 23:29 UTC

Market Talk

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 juil. 2025, 23:29 UTC

Market Talk

Global Energy Roundup: Market Talk

14 juil. 2025, 23:02 UTC

Résultats

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 juil. 2025, 23:02 UTC

Résultats

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 juil. 2025, 23:02 UTC

Résultats

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 juil. 2025, 23:01 UTC

Résultats

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 juil. 2025, 23:01 UTC

Résultats

China Vanke Expects 1H Loss to Widen >000002.SZ

14 juil. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

14 juil. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 juil. 2025, 20:07 UTC

Market Talk

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 juil. 2025, 20:05 UTC

Market Talk

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 juil. 2025, 19:11 UTC

Market Talk

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 juil. 2025, 19:09 UTC

Market Talk

Gold Breaks a 3-Day Win Streak -- Market Talk

14 juil. 2025, 18:59 UTC

Market Talk

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 juil. 2025, 18:30 UTC

Acquisitions, Fusions, Rachats

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 juil. 2025, 18:25 UTC

Market Talk

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 juil. 2025, 18:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 juil. 2025, 16:59 UTC

Market Talk

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 juil. 2025, 16:53 UTC

Actions en Tendance

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 juil. 2025, 16:27 UTC

Market Talk

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 juil. 2025, 16:20 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

14 juil. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 juil. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

14 juil. 2025, 16:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparaison

Variation de prix

Cyclacel Pharmaceuticals Inc prévision

Note du Consensus

By TipRanks

0 ratings

0

Achat

0

Maintien

0

Vente

Éléments financiers

$